Works matching AU Leverenz, James B.

Results: 227
    1

    Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 7, p. 1, doi. 10.1002/alz.70470
    By:
    • Goldman, Jennifer G.;
    • Boeve, Bradley F.;
    • Galasko, Douglas;
    • Taylor, John‐Paul;
    • Galvin, James E.;
    • Leverenz, James B.;
    • Blanc, Frederic;
    • Halliday, Glenda;
    • Kantarci, Kejal;
    • Lemstra, Afina W.;
    • Leroi, Iracema;
    • Lewis, Simon J. G.;
    • Litvan, Irene;
    • Medsger, Helen;
    • O'Brien, John;
    • Scholz, Sonja W.;
    • Aarsland, Dag;
    • Ikeda, Manabu;
    • McKeith, Ian;
    • Taylor, Angela
    Publication type:
    Article
    2
    3
    4

    Retinal Nerve Fiber Layer Thinning in Alzheimer’s Disease.

    Published in:
    American Journal of Alzheimer's Disease & Other Dementias, 2016, v. 31, n. 5, p. 430, doi. 10.1177/1533317515628053
    By:
    • Pillai, Jagan A.;
    • Bermel, Robert;
    • Bonner-Jackson, Aaron;
    • Rae-Grant, Alexander;
    • Fernandez, Hubert;
    • Bena, James;
    • Jones, Stephen E.;
    • Ehlers, Justis P.;
    • Leverenz, James B.
    Publication type:
    Article
    5
    6
    7
    8
    9

    Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.

    Published in:
    Annals of Clinical & Translational Neurology, 2019, v. 6, n. 4, p. 762, doi. 10.1002/acn3.755
    By:
    • Braggin, Jacquelyn E.;
    • Bucks, Stephanie A.;
    • Course, Meredith M.;
    • Smith, Carole L.;
    • Sopher, Bryce;
    • Osnis, Leah;
    • Shuey, Kiel D.;
    • Domoto‐Reilly, Kimiko;
    • Caso, Christina;
    • Kinoshita, Chizuru;
    • Scherpelz, Kathryn P.;
    • Cross, Chloe;
    • Grabowski, Thomas;
    • Nik, Seyyed H. M.;
    • Newman, Morgan;
    • Garden, Gwenn A.;
    • Leverenz, James B.;
    • Tsuang, Debby;
    • Latimer, Caitlin;
    • Gonzalez‐Cuyar, Luis F.
    Publication type:
    Article
    10

    Cognition among individuals along a spectrum of increased risk for Parkinson’s disease.

    Published in:
    PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201964
    By:
    • Chahine, Lana M.;
    • Urbe, Liz;
    • Caspell-Garcia, Chelsea;
    • Aarsland, Dag;
    • Alcalay, Roy;
    • Barone, Paolo;
    • Burn, David;
    • Espay, Alberto J.;
    • Hamilton, Jamie L.;
    • Hawkins, Keith A.;
    • Lasch, Shirley;
    • Leverenz, James B.;
    • Litvan, Irene;
    • Richard, Irene;
    • Siderowf, Andrew;
    • Coffey, Christopher S.;
    • Simuni, Tanya;
    • Weintraub, Daniel;
    • null, null
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Proteomic Identification of Novel Proteins in Cortical Lewy Bodies.

    Published in:
    Brain Pathology, 2007, v. 17, n. 2, p. 139, doi. 10.1111/j.1750-3639.2007.00048.x
    By:
    • Leverenz, James B.;
    • Umar, Imran;
    • Wang, Qing;
    • Montine, Thomas J.;
    • McMillan, Pamela J.;
    • Tsuang, Debby W.;
    • Jin, Jinghua;
    • Pan, Catherine;
    • Shin, Jenny;
    • Zhu, David;
    • Zhang, Jing
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease.

    Published in:
    1999
    By:
    • Lieberman, Andrew P.;
    • Trojanowski, John Q.;
    • Leonard, Debra G. B.;
    • Chen, Ke-Lian;
    • Barnett, Jeffrey L.;
    • Leverenz, James B.;
    • Bird, Thomas D.;
    • Robitaille, Yves;
    • Malandrini, Alessandro;
    • Fischbeck, Kenneth H.;
    • Lieberman, A P;
    • Trojanowski, J Q;
    • Leonard, D G;
    • Chen, K L;
    • Barnett, J L;
    • Leverenz, J B;
    • Bird, T D;
    • Robitaille, Y;
    • Malandrini, A;
    • Fischbeck, K H
    Publication type:
    journal article
    27
    28
    29

    Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 1, p. 1, doi. 10.1002/alz.14373
    By:
    • Xu, Jielin;
    • Song, Wenqiang;
    • Xu, Zhenxing;
    • Danziger, Michael M.;
    • Karavani, Ehud;
    • Zang, Chengxi;
    • Chen, Xin;
    • Li, Yichen;
    • Paz, Isabela M Rivera;
    • Gohel, Dhruv;
    • Su, Chang;
    • Zhou, Yadi;
    • Hou, Yuan;
    • Shimoni, Yishai;
    • Pieper, Andrew A.;
    • Hu, Jianying;
    • Wang, Fei;
    • Rosen‐Zvi, Michal;
    • Leverenz, James B.;
    • Cummings, Jeffrey
    Publication type:
    Article
    30
    31

    Sociodemographic and clinical heterogeneity among longitudinal studies in dementia with Lewy bodies.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S7, p. 1, doi. 10.1002/alz.092858
    By:
    • Kane, Joseph PM;
    • Rodriguez‐Porcel, Federico;
    • Bayram, Ece;
    • Abdelnour, Carla;
    • Desmarais, Philippe;
    • Echeverri, Isabella Delgado;
    • Ikeda, Manabu;
    • Gonzalez, Maria Camila;
    • Kanemoto, Hideki;
    • Poston, Kathleen L.;
    • Wyman‐Chick, Kathryn A;
    • Ricciardi, Mario;
    • Saeed, Usman;
    • Samancı, Bedia;
    • Satake, Yuto;
    • Yu, Yueyi;
    • Yu, Jin‐Tai;
    • Leverenz, James B;
    • Aarsland, Dag
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Sex‐dependent Biomarker Signatures in Alzheimer's Disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.092885
    By:
    • Jain, Lavanya;
    • Khrestian, Maria;
    • Tuason, Elizabeth D.;
    • Pillai, Jagan A.;
    • Rao, Stephen M.;
    • Leverenz, James B;
    • Bekris, Lynn M.
    Publication type:
    Article
    39
    40
    41

    Synuclein Aggregate Assay Performance in Autopsy‐Confirmed Lewy Body Dementia: Results from the U.S. Dementia with Lewy Bodies Consortium.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.088851
    By:
    • Leverenz, James B;
    • Patel, Purvi;
    • Formica, Shane;
    • Bekris, Lynn M.;
    • Tsuang, Debby W;
    • Zabetian, Cyrus P;
    • Litvan, Irene;
    • Fleisher, Jori E;
    • Berman, Sarah;
    • Irwin, David J;
    • Bozoki, Andrea;
    • Lippa, Carol;
    • Lopez, Oscar L.;
    • Galasko, Douglas R.
    Publication type:
    Article
    42
    43
    44

    Single‐Microglia Transcriptomic Transition Network‐based Prediction and Real‐world Patient Data Validation Identifies Ketorolac as a Repurposable Drug for Alzheimer's Disease.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, p. 1, doi. 10.1002/alz.089596
    By:
    • Xu, Jielin;
    • Danziger, Michael;
    • Xu, Zhenxing;
    • Zhang, Chengxi;
    • Zhou, Yadi;
    • Hou, Yuan;
    • Karavani, Ehud;
    • Shimoni, Yishai;
    • Pieper, Andrew A.;
    • Leverenz, James B;
    • Cummings, Jeffrey L.;
    • Hu, Jianying;
    • Wang, Fei;
    • Rosen‐Zvi, Michal;
    • Cheng, Feixiong
    Publication type:
    Article
    45
    46
    47
    48

    Lewy body dementia: Overcoming barriers and identifying solutions.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 2298, doi. 10.1002/alz.13674
    By:
    • Agarwal, Kanishka;
    • Backler, Wendi;
    • Bayram, Ece;
    • Bloom, Leah;
    • Boeve, Bradley F.;
    • Cha, Jang‐Ho;
    • Denslow, Maria;
    • Ferman, Tanis J.;
    • Galasko, Douglas;
    • Galvin, James E.;
    • Gomperts, Stephen N.;
    • Irizarry, Michael C.;
    • Kantarci, Kejal;
    • Kaushik, Harsh;
    • Kietlinski, Matt;
    • Koenig, Aaron;
    • Leverenz, James B.;
    • McKeith, Ian;
    • McLean, Pamela J.;
    • Montine, Thomas J.
    Publication type:
    Article
    49
    50